A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
Status:
COMPLETED
Trial end date:
2024-05-06
Target enrollment:
Participant gender:
Summary
This is a single-center, open, single-dose, self-controlled phase I clinical trial to evaluate the effects of metabolic enzyme inhibitors/inducers on in vivo metabolic and elimination of TQ05105 tablets, and the safety of metabolic enzyme inhibitors/inducers combined with TQ05105 tablets.